Biotech · Public company · Norwood, MA, US
Corbus Pharmaceuticals Holdings, Inc.
Ticker CRBP · SEC CIK 0001595097
Track this companyFree. Adds Corbus Pharmaceuticals Holdings, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials93 recruiting or active
Pipeline programs18From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline18
- capcitabinePhase 3 · Oropharyngeal Carcinoma (OPC)ClinicalTrials.gov · fetched Nov 12, 2026
- Cetuximab (EGFR inhibitor)Phase 3 · Oropharyngeal Carcinoma (OPC)ClinicalTrials.gov · fetched Nov 12, 2026
- CRB-701Phase 3 · Oropharyngeal Carcinoma (OPC)ClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 3 · Oropharyngeal Carcinoma (OPC)ClinicalTrials.gov · fetched Nov 12, 2026
- Lenabasum 20 mgPhase 3 · Diffuse Cutaneous Systemic SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Lenabasum 20 mgPhase 3 · DermatomyositisClinicalTrials.gov · fetched Nov 12, 2026
- Lenabasum 5 mgPhase 3 · DermatomyositisClinicalTrials.gov · fetched Nov 12, 2026
- Lenabasum 5 mgPhase 3 · Diffuse Cutaneous Systemic SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Anti-PD-1Phase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- Anti-PD-1 monoclonal antibodyPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- CRB-601 monoclonal antibodyPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- CRB-701Phase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- JBT-101Phase 2 · DermatomyositisClinicalTrials.gov · fetched Nov 12, 2026
- JBT-101Phase 2 · Diffuse Cutaneous Systemic SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Lenabasum 20 mgPhase 2 · Cystic FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- Lenabasum 5 mgPhase 2 · Cystic FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- Part B Open-Label ExtensionPhase 2 · Diffuse Cutaneous Systemic SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- CRB-913Phase 1 · Obese But Otherwise Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell CarcinomaPHASE3 · RECRUITING · started Sep 29, 2026ClinicalTrials.gov NCT07768189 · fetched Nov 12, 2026
- A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With ObesityPHASE1 · COMPLETED · started Dec 4, 2025ClinicalTrials.gov NCT07310901 · fetched Nov 12, 2026
- First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.PHASE1_PHASE2 · RECRUITING · started Dec 4, 2024ClinicalTrials.gov NCT06603844 · fetched Nov 12, 2026
- A Phase 1/2 Study to Investigate CRB-701 in Solid TumorsPHASE1_PHASE2 · RECRUITING · started Apr 1, 2024ClinicalTrials.gov NCT06265727 · fetched Nov 12, 2026
- Trial to Evaluate Efficacy and Safety of Lenabasum in DermatomyositisPHASE3 · COMPLETED · started Dec 17, 2018ClinicalTrials.gov NCT03813160 · fetched Nov 12, 2026
- Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic FibrosisPHASE2 · COMPLETED · started Dec 22, 2017ClinicalTrials.gov NCT03451045 · fetched Nov 12, 2026
- Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic SclerosisPHASE3 · TERMINATED · started Dec 18, 2017ClinicalTrials.gov NCT03398837 · fetched Nov 12, 2026
- Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic SclerosisPHASE2 · TERMINATED · started Aug 1, 2015ClinicalTrials.gov NCT02465437 · fetched Nov 12, 2026
- Safety, Tolerability, and Efficacy of JBT-101 in Subjects With DermatomyositisPHASE2 · TERMINATED · started Jun 1, 2015ClinicalTrials.gov NCT02466243 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 15, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 14, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 26, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 21, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 14, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026